MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0212967
Celesten Biopharmaceuticals Private Limited - pharma in Navi Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹13.44 Lakh
▼ 28% YoY
Net loss · FY 2025
₹5.22 Lakh
Net margin -38.8%
EBITDA · FY 2025
-₹5.17 Lakh
EBITDA margin -38.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Celesten Biopharmaceuticals Private Limited
Data last updated:
Celesten Biopharmaceuticals Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 September 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U52609MH2017PTC299850. Its GSTIN is 27AAHCC1988K1Z5 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Abhaysingh Shivaji Patankar and Anita Shivaji Patankar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No G – 100 Fantasia Business Park Plot No 47 Sector – 30A Vashi, Navi Mumbai, Maharashtra, India – 400703.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.44 Lakh, a decline of 28% compared to the previous year. For the same year it recorded a net loss of ₹5.22 Lakh (net margin -38.8%) and EBITDA of -₹5.17 Lakh (EBITDA margin -38.4%). Revenue has declined at a compounded annual rate (CAGR) of 23% over three years and 19% over five years.
Celesten Biopharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0212967). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website celestenbiopharma.in.
Company details
CIN U52609MH2017PTC299850
Registration Number 299850
Incorporation Date 18 September 2017
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0212967
Recognitions & Rankings of Celesten Biopharmaceuticals
Contact details
Celesten Biopharmaceuticals Private Limited's registered office is in Navi Mumbai, Maharashtra. Its website is celestenbiopharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressShop No G – 100 Fantasia Business Park Plot No 47 Sector – 30A Vashi, Navi Mumbai, Maharashtra, India – 400703
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Celesten Biopharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Celesten Biopharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Celesten Biopharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Celesten Biopharmaceuticals Private Limited, buy the company report.
Financials of Celesten Biopharmaceuticals Private Limited
FY 2025 filings availableCelesten Biopharmaceuticals Private Limited reported revenue of ₹13.44 Lakh (down 28% YoY) for FY 2025.
Revenue · FY 2025
₹13.44 Lakh ▼ 28%
Net loss · FY 2025
₹5.22 Lakh margin -38.8%
EBITDA · FY 2025
-₹5.17 Lakh margin -38.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 28%
3 years · compounded
▼ 23%
5 years · compounded
▼ 19%
EBITDA CAGR growth
1 year
▲ 40%
3 years · compounded
▲ 2%
5 years · compounded
▼ 10%
Revenue has declined at a compounded annual rate (CAGR) of 19% over five years, including a 28% fall in the latest year. EBITDA rose 40% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹5.17 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5.22 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -38.4% | ||||
| Net Profit Margin | -38.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Celesten Biopharmaceuticals Private Limited, buy the company report.
Board of directors of Celesten Biopharmaceuticals Private Limited
Celesten Biopharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abhaysingh Shivaji Patankar | Director | 08 Jan 2021 | 5 Years 9 Months | Current |
| Anita Shivaji Patankar Also directs: Shivan Precision Private Limited | Director | 01 Mar 2018 | 8 Years 8 Months | Current |
Peer comparison
Celesten Biopharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale and retail trade and repair of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Techtronics(India) Limited | ₹13.55 Lakh (FY 2025) | 359.0% | New Delhi, Delhi, India | |||
| Osheish Distribution Private Limited | ₹13.51 Lakh (FY 2025) | -27.0% | Mumbai, Maharashtra, India | |||
| Miron Pharmaceuticals Private Limited | ₹13.5 Lakh (FY 2024) | 15.0% | Nellore, Andhra Pradesh, India | |||
| Sawarkar Agro Industries Private Limited | ₹13.48 Lakh (FY 2025) | -83.0% | Nagpur, Maharashtra, India | |||
| Avinesh Exim Pvt. Ltd. | ₹13.45 Lakh (FY 2025) | 5.0% | Kolkata, West Bengal, India | |||
| Celesten Biopharmaceuticals Private Limitedthis company | ₹13.44 Lakh (FY 2025) | -₹5.22 Lakh | -38.8% | -28.0% | Navi Mumbai, Maharashtra, India | |
| 11 Stallion Marble and Granite Private Limited | ₹13.42 Lakh (FY 2024) | Haryana, India | ||||
| Dukul Clothing Private Limited | ₹13.4 Lakh (FY 2025) | 8.0% | Kamothe, Maharashtra, India | |||
| Safeakt Solution Private Limited | ₹13.39 Lakh (FY 2025) | 6.0% | Kolkata, West Bengal, India | |||
| Shasha Pharmaceuticals Private Limited | ₹13.39 Lakh (FY 2025) | 128.0% | Delhi, India | |||
| Solace India Limited | ₹13.3 Lakh (FY 2025) | -72.0% | New Delhi, Delhi, India |
To see the full peer comparison of Celesten Biopharmaceuticals Private Limited, buy the company report.
Auditor
Celesten Biopharmaceuticals Private Limited is audited by RAHUL PATIL & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAHUL PATIL & CO | FY 2023 | 170365 |
Shareholding
The shareholding of Celesten Biopharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Celesten Biopharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Celesten Biopharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Celesten Biopharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Celesten Biopharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCC1988K1Z5 | Maharashtra | Active | 11 Oct 2017 |
To see the full GST registrations and return filing status of Celesten Biopharmaceuticals Private Limited, buy the company report.
Recent activity
Celesten Biopharmaceuticals Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Abhaysingh Shivaji Patankar was appointed as Director on 08 Jan 2021.
AGM
Celesten Biopharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Celesten Biopharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Abhaysingh Shivaji Patankar was appointed as Director.
Ceased
Avinash Yashawantrao Choudhari ceased to be Director.
Ceased
Gyan Singh Pal ceased to be Director.
Appointed
Anita Shivaji Patankar was appointed as Director.
Incorporation
18 Sep 2017
Celesten Biopharmaceuticals Private Limited was registered on 18 Sep 2017 with Roc Mumbai & aged 9 years 1 month as per MCA records.
Frequently asked questions
Celesten Biopharmaceuticals is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 September 2017 (9+ years old) and is registered under CIN U52609MH2017PTC299850.
Celesten Biopharmaceuticals has 2 current directors:
- Abhaysingh Shivaji Patankar - Director
- Anita Shivaji Patankar - Director
The latest financial statements of Celesten Biopharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Celesten Biopharmaceuticals is 27AAHCC1988K1Z5, registered in Maharashtra.
The CIN (Corporate Identification Number) of Celesten Biopharmaceuticals is U52609MH2017PTC299850. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Celesten Biopharmaceuticals was incorporated on 18 September 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Celesten Biopharmaceuticals by revenue are Techtronics(India) Limited, Osheish Distribution Private Limited, Miron Pharmaceuticals Private Limited, Sawarkar Agro Industries Private Limited, Avinesh Exim Pvt. Ltd. and 5 more, all in the same principal business activity (wholesale and retail trade and repair of motor vehicles and motorcycles).
Abhaysingh Shivaji Patankar was appointed as Director on 08 Jan 2021. Avinash Yashawantrao Choudhari ceased to be Director on 08 Jan 2021. Gyan Singh Pal ceased to be Director on 10 Jun 2019. Celesten Biopharmaceuticals has 4 board changes on record in total.
Yes, Celesten Biopharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0212967).
Celesten Biopharmaceuticals can be reached through the website celestenbiopharma.in. Its registered office is in Navi Mumbai, Maharashtra, India.
The registered office of Celesten Biopharmaceuticals is at Shop No G – 100 Fantasia Business Park Plot No 47 Sector – 30A Vashi, Navi Mumbai, Maharashtra, India – 400703.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages